Polymorphisms of short tandem repeat of genes and breast cancer susceptibility

European Journal of Surgical Oncology

Volumn 33, Issue 5, 2007, Pages 529-534

  Zhang, W ^a   Yu, Y Y ^b  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

Author keywords

Breast cancer; Cancer susceptibility; Gene polymorphism; Tandem repeat sequence

Indexed keywords

ADENINE; ANDROGEN RECEPTOR; AROMATASE; BRCA1 PROTEIN; BRCA2 PROTEIN; CARCINOGEN; CHOLESTEROL MONOOXYGENASE (SIDE CHAIN CLEAVING); CYTOSINE; EPIDERMAL GROWTH FACTOR RECEPTOR 3; ESTRADIOL; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; GAMMA INTERFERON; GLUTAMINE; GUANINE; HISTONE METHYLTRANSFERASE; PESTICIDE; PROGESTERONE RECEPTOR; REGULATOR PROTEIN; SERINE; SEX HORMONE; SOMATOMEDIN C; STEROID HORMONE; STEROID RECEPTOR; STEROID RECEPTOR COACTIVATOR 3; TRANSCRIPTION FACTOR E2F4; TYROSINE;

BREAST CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CELL PROLIFERATION; CHROMOSOME 16Q; DISEASE COURSE; ENVIRONMENTAL EXPOSURE; GENE SEQUENCE; GENETIC POLYMORPHISM; HUMAN; MEDICAL LITERATURE; MEDLINE; MICROSATELLITE INSTABILITY; PRIORITY JOURNAL; REVIEW; SHORT TANDEM REPEAT;

BREAST NEOPLASMS; DISEASE SUSCEPTIBILITY; GENOTYPE; HUMANS; MICROSATELLITE REPEATS; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 34249088129     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejso.2006.11.027     Document Type: Review

References (34)

1. Tran N., Bharaj B.S., Diamandis E.P., Smith M., Li B.D.L., and Yu H. Short tandem repeat polymorphism and cancer risk: influence of laboratory analysis on epidemiologic findings. Cancer Epidemiol Biomarkers Prev 13 (2004) 2133-2140
2. Balasubramanian S.P., Cox B., Brown A.N.J., and Reed M.W. Candidate gene polymorphisms in solid cancers. Eur J Surg Oncol 30 6 (2004) 593-601
3. Liede A., Zhang W., Matsuda M.L.D.L., Tan A., and Narod S.A. Androgen receptor gene polymorphism and breast cancer susceptibility in the Philippines. Cancer Epidemiol Biomarkers Prev 12 (2003) 848-852
4. Sieh W., Edwards K.L., Fitzpatrick A.L., et al. Genetic susceptibility to prostate cancer: prostate-specific antigen and its interaction with the androgen receptor (United States). Cancer Causes Control 17 2 (2006) 187-197
5. Yu H., Bharaj B., Vassilikos E.J.K., Giai M., and Diamandis E.P. Shorter CAG repeat length in the androgen receptor gene is associated with more aggressive forms of breast cancer. Breast Cancer Res Treat 59 (2000) 153-161
6. Suter N.M., Malone K.E., Daling J.R., Doody D.R., and Ostrander E.A. Androgen receptor (CAG)n and (GGC)n polymorphisms and breast cancer risk in a population-based case-control study of young women. Cancer Epidemiol Biomarkers Prev 12 (2003) 127-135
7. Iobagiu C., Lambert C., Normand M., and Genin C. Microsatellite profile in hormonal receptor genes associated with breast cancer. Breast Cancer Res Treat 95 (2006) 153-159
8. Dagan E., Friedman E., Paperna T., Carmi N., and Gershoni-Baruch R. Androgen receptor CAG repeat length in Jewish Israeli women who are BRCA1/2 mutation carriers: association with breast/ovarian cancer phenotype. Eur J Hum Genet 10 (2002) 724-728
9. Spurdle A.B., Antoniou A.C., Duffy D.L., et al. The androgen receptor CAG repeat polymorphism and modification of breast cancer risk in BRCA1 and BRCA2 mutation carriers. Breast Cancer Res 7 (2005) R176-R183
10. Cai Q., Gao Y.-T., Wen W., et al. Association of breast cancer risk with a GT dinucleotide repeat polymorphism upstream of the estrogen receptor-α gene. Cancer Res 63 (2003) 5727-5730
11. Curran J.E., Lea R.A., Rutherford S., Weinstein S.R., and Griffiths L.R. Association of estrogen receptor and glucocorticoid receptor gene polymorphisms with sporadic breast cancer. Int J Cancer (Pred Oncol) 95 (2001) 271-275
12. Boyapati S.M., Shu X.O., Ruan Z.X., et al. Polymorphisms in ER-α gene interact with estrogen receptor status in breast cancer survival. Clinical Cancer Res 11 (2005) 1093-1098
13. Mironov N., Jansen L.A.M., Zhu W.-B., Aguelon A.-M., Reguer G., and Yamasaki H. A novel sensitive method to detect frameshift mutations in exonic repeat sequences of cancer-related genes. Carcinogenesis 20 11 (1999) 2189-2192
14. Schneider B.G., Bravo J.C., Roa J.C., et al. Microsatellite instability, prognosis and metastasis in gastric cancers from a low-risk population. Int J Cancer 89 (2000) 444-452
15. Ikeda M., Orimo H., Moriyama H., et al. Close correlation between mutations of E2F4 and hMSH3 genes in colorectal cancers with microsatellite instability. Cancer Res 58 (1998) 594-598
16. Ogata S., Tamura G., Endoh Y., Sakata K., Ohmura K., and Motoyama T. Microsatellite alterations and target gene mutations in the early stages of multiple gastric cancer. J Pathol 194 3 (2001) 334-340
17. Ho G.H., Calvano J.E., Bisogna M., and Van Zee K.J. Expression of E2F-1 and E2F-4 is reduced in primary and metastatic breast carcinomas. Breast Cancer Res Treat 69 (2001) 115-122
18. Haiman C., Hankinson S., Grahama D.I., et al. A tetranucleotide repeat polymorphism in CYP19 and breast cancer risk. Int J Cancer 87 (2000) 204-210
19. Dialyna I., Tzanakakis G., Dolapsakis G., and Tsatsakis A. A tetranucleotide repeat polymorphism in the CYP19 gene and breast cancer susceptibility in a Greek population exposed and not exposed to pesticides. Toxicol Lett 151 (2004) 267-271
20. Han D., Zhou X., Hu M., et al. Polymorphisms of estrogen-metabolizing genes and breast cancer risk: a multigenic study. Chinese Medical Journal 118 18 (2005) 1507-1516
21. Ribeiro F.S., Amorim L.M.D.F., Simão T.D.A., Mendonça G.A., Moura Gallo C.V.D., and Pinto L.F.R. CYP19 (TTTA)n polymorphism and breast cancer risk in Brazilian women. Toxicol Lett 164 1 (2006) 90-95
22. Zheng W., Gao Y.-T., Shu X.-O., et al. Population-based case-control study of CYP11A gene polymorphism and breast cancer risk. Cancer Epidemiol Biomarkers Prev 13 (2004) 709-714
23. Cleveland R.J., Gammon M.D., Edmiston S.N., et al. IGF1 CA repeat polymorphisms, lifestyle factors and breast cancer risk in the Long Island Breast Cancer Study Project. Carcinogenesis 27 4 (2006) 758-765
24. Setiawan V.W., Cheng I., Stram D.O., et al. IGF-I genetic variation and breast cancer: the multiethnic cohort. Epidemiol Biomarkers Prev 15 (2006) 172-174
25. Dai P., and Wong L.J.C. Somatic instability of the DNA sequences encoding the polymorphic polyglutamine tract of the AIB1 gene. J Med Genet 40 (2003) 885-890
26. Kadouri L., Kote-Jarai Z., Easton D.F., et al. Polyglutamine repeat length in the AIB1 gene modifies breast cancer susceptibility in BRCA1 carriers. Int J Cancer 108 3 (2004) 399-403
27. Spurdle A.B., Antoniou A.C., Kelemen L., et al. The AIB1 polyglutamine repeat does not modify breast cancer risk in BRCA1 and BRCA2 mutation carriers. Cancer Epidemiol Biomarkers Prev 15 1 (2006) 76-79
28. Christopher A.H., Hankinson S.E., Spiegelman D., et al. Polymorphic repeat in AIB1 does not alter breast cancer risk. Breast Cancer Res 2 (2000) 378-385
29. Hughes D.J., Ginolhac S.M., Coupier I., et al. Breast cancer risk in BRCA1 and BRCA2 mutation carriers and polyglutamine repeat length in the AIB1 gene. Int J Cancer 117 2 (2005) 230-233
30. Saha A., Dhir A., Ranjan A., Gupta V., Bairwa N., and Bamezai R. Functional IFNG polymorphism in intron 1 in association with an increased risk to promote sporadic breast cancer. Immunogenetics 57 3-4 (2005) 165-171
31. Tsuge M., Hamamoto R., Silva F.P., et al. A variable number of tandem repeats polymorphism in an E2F-1 binding element in the 5′ flanking region of SMYD3 is a risk factor for human cancers. Nat Genet 37 (2005) 1104-1107
32. Tidow N., Boecker A., Schmidt H., et al. Distinct amplification of an untranslated regulatory sequence in the EGFR gene contributes to early steps in breast cancer development. Cancer Res 63 (2003) 1172-1178
33. Gebhardt F., Zanker K.S., and Brandt B. Modulation of epidermal growth factor receptor gene transcription by polymorphic dinucleotide repeat in intron 1. J Biol Chem 274 (1999) 13176-13180
34. Buerger H., Packeisen J., Boecker A., et al. Allelic length of a CA dinucleotide repeat in the egfr gene correlates with the frequency of amplifications of this sequence-first results of an inter-ethnic breast cancer study. J Pathol 203 (2004) 545-550